• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1012462-28
Device Problems Peeled/Delaminated (1454); Improper or Incorrect Procedure or Method (2017); Failure to Advance (2524)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/25/2014
Event Type  malfunction  
Event Description
The procedure was to treat a moderately tortuous, mildly calcified, de novo lesion in the right coronary artery (rca).The 2.5x28 mm device did not cross the lesion even after adequate pre-dilatation with a semi complaint balloon (residual stenosis was close to 50%).Proximal calcification was suspected and the device was removed.Without further dilatation, the procedure was completed using a xience xpedition of the same size.There was no clinically significant delay in the procedure and no adverse patient effects.No additional information was provided.The returned device evaluation found that there was balloon material shredding at the proximal balloon shaft.
 
Manufacturer Narrative
(b)(4).Residual stenosis was close to 50%.The device was received.Investigation is not yet complete.A follow up report will be submitted with all relevant information.Though the device is not approved for sale in the u.S., it uses a delivery system which is similar to a device sold in the u.S.
 
Manufacturer Narrative
(b)(4).Evaluation summary: the device was returned for evaluation.The failure to advance could not be replicated in a testing environment as it was based on operational circumstances.However, there was balloon material shredding at the proximal balloon shaft.Based on visual and dimensional analysis of the returned device, there is no indication of a product deficiency.A review of the lot history record revealed no non-conformances that would have contributed to this complaint.A query/review of the complaint history of the reported lot did not indicate a manufacturing issue.It should be noted that the instructions for use (ifu), warns: it is not recommended to treat patients having a lesion that prevents complete inflation of an angioplasty balloon, or a lesion with greater than 40% residual stenosis after pre-dilatation by visual estimation.Based on the information reviewed, there is no indication of a product deficiency.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 462
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 462
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key4358917
MDR Text Key5174391
Report Number2024168-2014-08489
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
P070015
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial,Followup
Report Date 10/07/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2015
Device Catalogue Number1012462-28
Device Lot Number4040161
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer12/02/2014
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/02/2015
Initial Date FDA Received12/23/2014
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received01/14/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/01/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-